Thomas J. Gould

Thomas J. Gould

Auto-generated profile, based on publicly available information

Thomas J. Gould

Department of Biobehavioral Health, the Pennsylvania State University, University Park, PA, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
SLSheree F. Logue
Sheree F. Logue
TGThomas J. Gould
Thomas J. Gould

9 August 2008 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
JKJustin W. Kenney
Justin W. Kenney
TGThomas J. Gould
Thomas J. Gould

21 September 2005 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JDJennifer A. Davis
Jennifer A. Davis
JJJohn R. James
John R. James
SSSteven Siegel
Steven Siegel
TGThomas J. Gould
Thomas J. Gould
The effects of acute nicotine administration (0.09 mg/kg nicotine), chronic nicotine administration (6.3 mg/kg/d nicotine for 14 d), and withdrawal from chronic nicotine administration on fear conditioning in C57BL/6 mice were examined. Mice were trained using two coterminating conditioned stimulus (30 s; 85 dB white noise)–unconditioned stimulus (2 s; 0.57 mA foot shock) pairings and tested 24 h later for contextual and cued fear conditioning. Acute nicotine administration enhanced contextual fear conditioning, chronic nicotine administration had no effect on contextual fear conditioning, and withdrawal from chronic nicotine administration impaired contextual fear conditioning. Plasma nicotine concentrations were similar after acute and chronic treatment and were within the range reported for smokers. During withdrawal, concentrations of nicotine were undetectable. An acute dose of nicotine (0.09 mg/kg) during withdrawal from chronic nicotine treatment reversed withdrawal-associated deficits in contextual fear conditioning. The results suggest that tolerance to the effects of nicotine on contextual fear conditioning develops with chronic nicotine treatment at a physiologically relevant dose, and withdrawal from this chronic nicotine treatment is associated with impairments in contextual fear conditioning. These findings provide a model of how the effects of nicotine on learning may contribute to the development and maintenance of nicotine addiction.

1 December 2010
Verified
Journal Article
Closed access
TGThomas J. Gould
Thomas J. Gould

1 September 2003 in Neurobiology of Learning and Memory
Verified
Journal Article
Closed access
TGThomas J. Gould
Thomas J. Gould
JHJ. Stephen Higgins
J. Stephen Higgins

3 October 2007 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JDJennifer A. Davis
Jennifer A. Davis
JKJustin W. Kenney
Justin W. Kenney
TGThomas J. Gould
Thomas J. Gould
Nicotine is known to enhance learning and memory in hippocampus-dependent tasks such as contextual fear conditioning. The present study was designed to directly examine whether the hippocampus plays a role in mediating this enhancement and which nicotinic acetylcholine receptor (nAChR) subtypes localized to the hippocampus are critical for enhanced learning. Contextual fear conditioning consisted of two white noise conditioned stimuli presentations, each coterminating with a 2 s, 0.57 mA footshock separated by a 120 s intertrial interval. Nicotine (0.09, 0.18, and 0.35 μg per side) was bilaterally infused into the dorsal hippocampus before training and testing. Infusions of nicotine into the dorsal hippocampus produced a dose-dependent enhancement of contextual fear conditioning. To determine which nAChRs are critical to the enhancing effect of nicotine, the preferential α4β2 nAChR antagonist, dihydro-β-erythroidine (DHβE) (6.00 and 18.00 μg per side), or the preferential α7 nAChR antagonist, methyllycaconitine (MLA) (13.50 and 27.00 μg per side), was bilaterally infused into the dorsal hippocampus before systemic injections of nicotine (0.09 mg/kg). DHβE infusions dose-dependently blocked the enhancement of contextual fear conditioning by nicotine, whereas MLA infusions yielded an intermediate effect. In addition, neither DHβE nor MLA had an effect on contextual fear conditioning in the absence of systemic nicotine. The present results suggest a critical role for α4β2 nAChRs in the dorsal hippocampus for mediating the enhancing effect of nicotine on contextual fear conditioning.